Small molecule inhibitors of the human papillomavirus E1-E2 interaction.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Current Topics in Microbiology and Immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/82_2010_92PMID 20676971
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®)

  2012cited by this paper
• Cervarix™: a vaccine for the prevention of HPV 16, 18-associated cervical cancer

  2008cited by this paper
• Recent Advances in the Search for Antiviral Agents against Human Papillomaviruses

  2007cited by this paper
• Optimization and determination of the absolute configuration of a series of potent inhibitors of human papillomavirus type-11 E1-E2 protein-protein interaction: a combined medicinal chemistry, NMR and computational chemistry approach.

  2007cited by this paper
• Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity

  2006influential reference
• Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins.

  2006cited by this paper
• Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis.

  2006cited by this paper
• Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association.

  2006cited by this paper
• Biphenylsulfonacetic Acid Inhibitors of the Human Papillomavirus Type 6 E1 Helicase Inhibit ATP Hydrolysis by an Allosteric Mechanism Involving Tyrosine 486

  2005cited by this paper
• The HPV xenograft severe combined immunodeficiency mouse model.

  2005cited by this paper
• Differentiation of HPV-containing cells using organotypic "raft" culture or methylcellulose.

  2005cited by this paper
• Biocalorimetry: Applications of Calorimetry in the Biological Sciences

  2005cited by this paper
• Characterization of the binding site for inhibitors of the HPV11 E1-E2 protein interaction on the E2 transactivation domain by photoaffinity labeling and mass spectrometry.

  2004cited by this paper
• Discovery of small-molecule inhibitors of the ATPase activity of human papillomavirus E1 helicase.

  2004cited by this paper
• The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2.

  2004cited by this paper
• NMR structural characterization of peptide inhibitors bound to the Hepatitis C virus NS3 protease: design of a new P2 substituent.

  2004cited by this paper
• Crystal Structure of the E2 Transactivation Domain of Human Papillomavirus Type 11 Bound to a Protein Interaction Inhibitor*

  2004influential reference
• Inhibition of Human Papillomavirus DNA Replication by Small Molecule Antagonists of the E1-E2 Protein Interaction*

  2003influential reference
• Discovery of the first series of inhibitors of human papillomavirus type 11: inhibition of the assembly of the E1-E2-Origin DNA complex.

  2003cited by this paper
• Structure Elucidation of the First Inhibitors of Human Papillomavirus Type 11 E1E2 ProteinProtein Interaction

  2003cited by this paper
• Inhibition of protein-protein association by small molecules: approaches and progress.

  2002cited by this paper
• Papillomaviruses and cancer: from basic studies to clinical application

  2002cited by this paper
• Characterization of Recombinant HPV6 and 11 E1 Helicases

  2001cited by this paper
• NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain.

  2000cited by this paper
• Crystal structure of the DNA binding domain of the replication initiation protein E1 from papillomavirus.

  2000cited by this paper
• Structure of the intact transactivation domain of the human papillomavirus E2 protein

  2000cited by this paper
• Crystal structure of the human papillomavirus type 18 E2 activation domain.

  1999cited by this paper
• Biochemical and Electron Microscopic Image Analysis of the Hexameric E1 Helicase*

  1999cited by this paper
• Role of the ATP-Binding Domain of the Human Papillomavirus Type 11 E1 Helicase in E2-Dependent Binding to the Origin

  1999influential reference
• Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism.

  1998cited by this paper
• Identification of single amino acids in the human papillomavirus 11 E2 protein critical for the transactivation or replication functions.

  1998cited by this paper
• Repaglinide and related hypoglycemic benzoic acid derivatives.

  1998influential reference
• Recruitment and loading of the E1 initiator protein: an ATP‐dependent process catalysed by a transcription factor

  1998cited by this paper
• Isothermal titration calorimetry of biomolecules

  1998cited by this paper
• Genetic analysis of the activation domain of bovine papillomavirus protein E2: its role in transcription and replication

  1996cited by this paper
• Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions

  1996cited by this paper
• Principles of protein-protein interactions.

  1996cited by this paper
• Solution structure of the DNA-binding domain of a human papillomavirus E2 protein: evidence for flexible DNA-binding regions.

  1996cited by this paper
• Domains of the BPV-1 E1 replication protein required for origin-specific DNA binding and interaction with the E2 transactivator.

  1995cited by this paper
• Human papillomaviruses.

  1994cited by this paper
• Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts.

  1994cited by this paper
• The bovine papillomavirus E2 protein modulates the assembly of but is not stably maintained in a replication-competent multimeric E1-replication origin complex.

  1994cited by this paper
• Human papillomaviruses.

  1994cited by this paper
• Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication.

  1993cited by this paper
• Crystal structure at 1.7 Å of the bovine papillomavirus-1 E2 DMA-binding domain bound to its DNA target

  1992cited by this paper
• The in vitro replication of DNA containing the SV40 origin.

  1990cited by this paper
• Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells.

  1990cited by this paper

• In Silico Identification of Potential Antagonists Targeting the HPV16 E2-E1 Interaction: A Step Toward Novel Therapeutics for Cervical Cancer

  2025cites this paper
• In-silico discovery of inhibitors against human papillomavirus E1 protein

  2022influential citation
• Analysis of physicochemical properties of protein-protein interaction modulators suggests stronger alignment with the "rule of five".

  2021cites this paper
• E1 and E2 Viral Proteins as Therapeutic Targets for Development of Antiviral Agents

  2019cites this paper
• Small Molecule Inhibitors Targeting New Targets of Protein-Protein Interactions

  2018cites this paper
• Development of Protein-Protein Interaction Inhibitors for the Treatment of Infectious Diseases.

  2018cites this paper
• Análisis de procesos de transcripción, traducción y degradación del virus del arabesco del pelargonium

  2017cites this paper
• Anti-tumor Mechanisms of HPV16 E6*

  2016cites this paper
• Desenvolvimento de duas plataformas biotecnológicas baseadas em Pichia pastoris e Leishmania tarentolae para produção de candidatos vacinais contra os Papilomavírus humano (HPV) e bovino (BPV)

  2016cites this paper
• Prospects of molecularly-targeted therapies for cervical cancer treatment.

  2015cites this paper
• Human Papillomavirus-Related Cancers

  2015cites this paper
• Multiple Roles of Brd4 in the Human Papillomavirus Life Cycle

  2014cites this paper
• Analysis of the Papillomavirus E2 and Bromodomain Protein Brd4 Interaction Using Bimolecular Fluorescence Complementation

  2013cites this paper
• Modern Molecular and Clinical Approaches to Eradicate HPVMediated Cervical Cancer

  2013cites this paper
• Antiviral medication in sexually transmitted diseases. Part I: HSV, HPV.

  2013cites this paper
• Discovering New Medicines Targeting Helicases: Challenges and Recent Progress

  2013influential citation
• Protein-protein interactions: network analysis and applications in drug discovery.

  2012cites this paper
• A small molecule screen in yeast identifies inhibitors targeting protein-protein interactions within the vaccinia virus replication complex.

  2012cites this paper
• Therapy of human papillomavirus-related disease.

  2012cites this paper
• Genital human papillomavirus infections: current and prospective therapies.

  2012influential citation
• Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins.

  2012cites this paper
• The E1 Protein of Human Papillomavirus Type 16 Is Dispensable for Maintenance Replication of the Viral Genome

  2012cites this paper
• Inhibition of protein-protein interactions in Plasmodium falciparum: future drug targets.

  2012cites this paper
• Protein-Protein Interactions as Drug Targets

  2012cites this paper
• Oncogenic Aspects of HPV Infections of the Female Genital Tract

  2011cites this paper
• Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I).

  2011cites this paper
• Small Molecule Inhibitors of Human Papillomavirus Protein - Protein Interactions

  2011cites this paper
• Onkogeni aspekti HPV-genitalnih infekcija kod žena

  2011cites this paper